Healthcare / Medical Care FacilitiesNSE
$169.29
-3.52 (-2.04%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 17%
FCF escenarios
weak_data · normalized FCF $-275.1M · quality 39.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
48/100
C
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$18.2B
P/E
217.0x
↑EV/EBITDA
14.4x
↑ROE
0.6%
↑Gross Margin
41.2%
↓Debt/Equity
0.48
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+15.6%
FCF CAGR
—
FCF margin
-7.0%
FCF / Net income
-12.18x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $10.81B · net income $62.2M · FCF $-757.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $10.81B | $10.81B | $9.28B | $8.00B | $6.99B |
| Net Income | $62.2M | $62.2M | $840.8M | $677.0M | $541.3M |
| EBITDA | $1.57B | $1.57B | $1.95B | $1.58B | $1.28B |
| EPS | 0.58 | 0.58 | 7.83 | 6.30 | 5.00 |
| Gross Margin | 41.2% | 41.2% | 45.6% | 45.6% | 43.6% |
| Operating Margin | 7.2% | 7.2% | 13.8% | 11.7% | 11.8% |
| Net Margin | 0.6% | 0.6% | 9.1% | 8.5% | 7.7% |
| Balance Sheet | |||||
| Debt/Equity | 0.48 | 0.48 | 0.38 | 0.19 | 0.20 |
| Current Ratio | 1.25 | 1.25 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-757.9M | $-757.9M | $-275.1M | $492.9M | $-564.8M |
| Returns | |||||
| ROE | 0.6% | 0.6% | 8.4% | 7.3% | 6.2% |
| Valuation | |||||
| P/E | 217.04 | 217.04 | 34.14 | 22.37 | 26.57 |
| EV/EBITDA | 14.42 | 14.42 | 16.53 | 10.64 | 12.15 |
| P/B | 1.83 | 1.83 | 2.87 | 1.63 | 1.64 |
| Growth & Yield | |||||
| Revenue Growth | 16.4% | 16.4% | 16.1% | 14.4% | — |
| EPS Growth | -92.6% | -92.6% | 24.3% | 26.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
196.0%
EPS terminal req.
$15.02
Spread vs growth
-288.7%
5Y implied EPS CAGR
99.2%
EPS terminal req.
$18.18
Spread vs growth
-191.8%
10Y implied EPS CAGR
48.0%
EPS terminal req.
$29.27
Spread vs growth
-140.6%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-15.6%
Start / end P/E
25.5x → 291.6x
EPS bridge
7.83 → 0.58
Residual
-964.4%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.